News about Drug Discovery & Development

Inoviv Introduces MasterKey for Multiplexed Targeted Protein Assays

Inoviv has developed MasterKey, which enables researchers to select specific proteins from a comprehensive, pre-characterized catalog of thousands of proteins.

Drug Discovery & Development | 01/08/2024 | By Aishwarya |  659

Zydus Gets Approval from COFEPRIS to Market Mamitra

Zydus Lifesciences has announced that COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) has granted marketing approval for Mamitra, a Trastuzumab biosimilar.

Drug Discovery & Development | 31/07/2024 | By Aishwarya |  853

OneSource Signs Licensing Deal with BRL to Deliver High-Concentration Biologic Products

OneSource Specialty Pharma Ltd. has signed a strategic licensing agreement with Bhami’s Research Laboratory (BRL).

Drug Discovery & Development | 30/07/2024 | By Aishwarya |  868

Luye Pharma Gets US FDA Approval of ERZOFRI Extended-Release Injectable Suspension

Luye Pharma Group has announced that the US Food and Drug Administration (FDA) has approved the company's ERZOFRI (paliperidone palmitate) extended-release injectable suspension, for treating schizophrenia in adults and for treating schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.

Drug Discovery & Development | 30/07/2024 | By Aishwarya |  799

Innovent and WeComput to Accelerate AI-Driven Drug Discovery and Development

Innovent Biologics, Inc. has forged a strategic partnership with WeComput to jointly advance the construction and improvement of Innovent Biologics' Artificial Intelligence for Drug Discovery platform.

Drug Discovery & Development | 26/07/2024 | By Aishwarya |  605

Sun Pharma Gets US FDA Approval for LEQSELVI for Treatment of Severe Alopecia Areata

Sun Pharmaceutical Industries Ltd. has announced that the US Food and Drug Administration (FDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata.

Drug Discovery & Development | 26/07/2024 | By Aishwarya |  1234

Lupin and Huons to Commercialize Cyclosporine Ophthalmic Nanoemulsion in Mexico

Lupin has signed a license and supply deal with Huons Co. Ltd. for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, a 0.4mL Single-use Vial, in Mexico.

Drug Discovery & Development | 24/07/2024 | By Aishwarya |  618

Rona Therapeutics Secures USD 35 Million in Series A+ Financing

Rona Therapeutics has received USD 35 million in Series A+ financing round.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  571

Glenmark Gets ANDA Approval for Topiramate Capsules

Glenmark Pharmaceuticals Ltd. has been granted final approval by the United States Food and Drug Administration (US FDA) for Topiramate Capsules USP, 15 mg and 25 mg.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  635

Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India

Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  1126